Skip to main content
. Author manuscript; available in PMC: 2021 Sep 17.
Published in final edited form as: Mol Psychiatry. 2020 May 12;26(6):2070–2081. doi: 10.1038/s41380-020-0705-9

Table 4.

Results for SNPs that were genome-wide significant in the conditional analysis and have larger estimated conditional effect sizes than in the original GWAS

Disorder SNP CHR Position A1 Adjusted beta SE Adjusted beta Unadjusted beta SE Unadjusted beta Adjusted p-value Unadjusted p-value nearestGene
SCZ rs3764002 12 108618630 C 0.083 0.012 0.054 0.011 1.94E-12 6.05E-07 WSCD2
SCZ rs6095357 20 47523865 A −0.069 0.011 −0.048 0.010 1.17E-10 1.21E-06 ARFGEF2
SCZ rs7790864 7 28478625 A −0.062 0.011 −0.044 0.010 6.33E-09 7.18E-06 CREB5
SCZ rs1054972 19 1852582 A 0.076 0.013 0.053 0.012 6.42E-09 1.32E-05 KLF16
SCZ rs2867673 7 71752652 T 0.060 0.010 0.049 0.010 9.44E-09 4.11E-07 CALN1
SCZ rs6564668 16 79457393 C −0.060 0.010 −0.038 0.010 1.05E-08 7.94E-05 RP11-467I7.1
SCZ rs11922765 3 95047279 G −0.060 0.010 −0.044 0.010 1.22E-08 4.36E-06 RPS18P6
SCZ rs2973038 5 37833781 C 0.066 0.012 0.051 0.011 1.28E-08 1.72E-06 GDNF
SCZ rs10903945 10 363275 C 0.057 0.010 0.040 0.010 3.13E-08 3.30E-05 DIP2C
SCZ rs10282935 8 38703797 A 0.058 0.011 0.041 0.010 3.97E-08 3.17E-05 TACC1
SCZ rs6701877 1 174015259 G −0.096 0.014 −0.073 0.013 1.47E-11 2.37E-08 RP11-160H22.3
SCZ rs7372313 3 135872958 G −0.069 0.010 −0.062 0.010 4.26E-11 1.54E-10 MSL2
SCZ rs1765142 11 30378559 C 0.065 0.011 0.058 0.010 1.54E-09 1.13E-08 ARL14EP
SCZ rs55646993 7 105017864 G −0.062 0.010 −0.053 0.010 2.23E-09 3.83E-08 SRPK2
SCZ rs150437760 14 59981768 A 0.131 0.024 0.121 0.022 3.71E-08 4.58E-08 CCDC175
BIP rs12554512 9 23352293 T −0.083 0.014 −0.066 0.014 1.55E-09 1.28E-06 ELAVL2
BIP rs6891181 5 80849101 T −0.081 0.014 −0.075 0.014 1.49E-08 1.27E-07 SSBP2
BIP rs12268910 10 111878510 T −0.097 0.018 −0.091 0.018 3.29E-08 2.73E-07 ADD3
MD rs11697370 20 47731767 T −0.031 0.005 −0.023 0.005 3.31E-09 3.53E-06 STAU1
MD rs27732 5 87992576 A 0.034 0.005 0.031 0.005 1.22E-11 1.87E-10 MEF2C
MD rs1806153 11 31850105 T 0.037 0.006 0.036 0.006 8.78E-10 1.18E-09 RCN1
MD rs1354115 9 2983774 A 0.029 0.005 0.028 0.005 1.72E-08 2.37E-08 CARM1P1
MD rs301799 1 8489302 T −0.028 0.005 −0.026 0.005 2.49E-08 4.68E-08 RERE
ADHD rs78648104 6 50683009 T 0.136 0.023 0.124 0.025 4.31E-09 3.60E-07 TFAP2D
ADHD rs2244336 10 8831827 C 0.071 0.013 0.069 0.014 3.81E-08 3.67E-07 ENSG00000270234
ADHD rs12410444 1 44188719 A 0.107 0.014 0.106 0.015 4.23E-15 3.85E-13 ST3GAL3
ADHD rs13023832 2 215219808 A 0.133 0.020 0.117 0.021 1.23E-11 1.62E-08 SPAG16
ADHD rs281320 15 47769424 T −0.080 0.013 −0.074 0.013 1.84E-10 3.14E-08 SEMA6D
AUT rs10099100 8 10576775 C 0.084 0.014 0.084 0.015 1.20E-09 1.07E-08 SOX7